Journal Article

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

  • Dwyer J
  • Landeros-Weisenberger A
  • Johnson J
  • et al.
Focus (2022) 20(2) 241-251
DOI: 10.1176/appi.focus.22020004
N/ACitations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective:Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, it...

Cite

CITATION STYLE

APA

Dwyer, J. B., Landeros-Weisenberger, A., Johnson, J. A., Londono Tobon, A., Flores, J. M., Nasir, M., … Bloch, M. H. (2022). Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. Focus, 20(2), 241–251. https://doi.org/10.1176/appi.focus.22020004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free